Clinical trial
ISO-101 a Novel Device for the Treatment of Orthostatic Hypotension - a Signal of Efficacy Study
NCT06039410 is registered in ClinicalTrials.gov with Isotech Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ISO-101 a Novel Device for the Treatment of Orthostatic Hypotension - a Signal of Efficacy Study
- Lead sponsor
- Isotech Ltd
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 15, 2023
- Completion date
- March 31, 2024
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
orthostatic hypotension